Conclusions: TIMI risk score can be used for long term prognostication of NSTE-ACS patients after revascularization, and thus can be used by clinicians for therapeutic decision making. The relative risk increased by 66% as the TIMI risk score increased from low risk category (TIMI score 0-2) to high risk (TIMI score 5-6). Event rates increased significantly as the TIMI risk score increased as determined by regression analysis (p=0.004). The event rates of the primary endpoint and its components after 36 months were 26.6%. Background: Demographic data and comparative performance of both TIMI (Thrombolysis in myocardial infarction) and GRACE (global registry in acute coronary. Results: Baseline characteristics for 150 participants were as follows, age 56☙.5 years, 78.7% male, 25% diabetics, 82% hypertensives, and 36% had hypercholesterolemia. Clinical secondary endpoints included the individual components of the primary endpoint, death, nonfatal recurrent MI, and repeat target vessel revascularization. In-hospital events grouped by TIMI score were 38.1 in TIMI high, 25.4 in TIMI medium, and 14.5 in TIMI low-risk patients (Table 2). The primary endpoint was a composite of MACE ( death, repeat target-vessel revascularization, and non-fatal recurrent MI) at the end of 36 months of follow up. TIMI risk score was calculated for each patient at admission. Methods: This was a retrospective observational cohort study of consecutive NSTE-ACS patients (n=150) treated by percutaneous coronary intervention between January 2017 to June 2017 in a tertiary care center. This study aims at assessing the long term prognostic significance of TIMI risk score, 36 months after revascularization in NSTE-ACS. Thirty-day mortality rates were higher among patients with higher TIMI scores (TIMI score 2: 4. However, few studies have evaluated the long term prognostic significance of TIMI risk score after revascularization. The cohort’s median TIMI score was 6 (25th75th percentile 4, 8). Primarily thrombolysis in myocardial infarction (TIMI) risk score was developed to guide therapy and assess the short term (14 days) prognosis of these patients. ABSTRACT Background: Non-ST elevation acute coronary syndrome (NSTE-ACS) patients are complex and varied population.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |